Evaluating the Prognostic Role of Monocytopenia in Chemotherapy-Induced Febrile Neutropenia Patients Treated with Granulocyte Colony-Stimulating Factor.

Osama Alshari Yazan O Al Zu'bi Ahmed H Al Sharie Farouk H WafaiAbdelwahab J AleshawiFarah H AtawnehHasan A ObeidatMajd N DaoudMohammad Z KhraisDima AlbalsFaize Tubaishat

Published in: Therapeutics and clinical risk management (2021)

Monocytopenia holds a worse prognosis in chemotherapy-induced febrile neutropenia patients treated with G-CSF. In addition, AMC values at presentation represents a potential risk factor that can predict short-term changes regarding ANC measures.

Keyphrases

chemotherapy induced
risk factors
peripheral blood
case report
climate change